ANVS insider filings
Annovis Bio, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-06. Screen ANVS transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 1 insider filing (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing by 1 insider — 5,000,000 shares, $5,000,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 1.
- Largest priced transaction: purchase of 5,000,000 shares @ $1.00 ($5,000,000) by Hoffman Michael B, filed 2026-11-06.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Hoffman Michael B — Director | 1 | 1 leg · 5,000,000 sh · $5,000,000 | — | 1 |
Recent insider filings — Annovis Bio, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-06 | 4 | Hoffman Michael B — Director | Purchase (P): 5,000,000 @ $1 · Purchase (P): 5,000,000 (derivative) @ $0 | EDGAR |
| 2026-05-21 | 4 | Hoffman Michael B — Director | Purchase (P): 2,562 @ $1.75 · Purchase (P): 18,849 @ $1.80 · Purchase (P): 54,933 @ $1.90 | EDGAR |
| 2026-04-03 | 4 | Hoffman Michael B — Director | Purchase (P): 713,800 @ $2.10 | EDGAR |
| 2025-12-08 | 4 | Hoffman Michael B — Director | Purchase (P): 30,000 @ $4.34 · Purchase (P): 15,000 @ $4.24 | EDGAR |
| 2025-11-25 | 4 | Hoffman Michael B — Director | Purchase (P): 1,489 @ $4.13 · Purchase (P): 9,200 @ $3.85 · Purchase (P): 415 @ $4.14 · Purchase (P): 28,096 @ $4.15 | EDGAR |
| 2025-11-25 | 4/A | Hoffman Michael B — Director | Purchase (P): 1,489 @ $4.13 · Purchase (P): 9,200 @ $3.85 · Purchase (P): 415 @ $4.14 · Purchase (P): 28,096 @ $4.15 | EDGAR |
| 2025-11-21 | 4 | Hoffman Michael B — Director | Purchase (P): 10,000 @ $3.49 · Purchase (P): 10,000 @ $3.50 | EDGAR |
| 2025-11-18 | 4 | Hoffman Michael B — Director | Purchase (P): 15,000 @ $2.11 | EDGAR |
| 2025-11-12 | 4 | Bruck Claudine — Director | Option exercise (M): 7,142 @ $0.14 · Option exercise (M): 7,142 (derivative) @ $0 | EDGAR |
| 2025-11-12 | 4 | Maccecchini Maria-Luisa — President & CEO, Director | Purchase (P): 97,561 @ $2.05 | EDGAR |
| 2025-11-12 | 4 | Hoffman Michael B — Director | Purchase (P): 975,610 @ $2.05 | EDGAR |
| 2025-09-03 | 4 | Hoffman Michael B — Director | Grant/award (A): 5,000 @ $2.28 · Grant/award (A): 5,000 @ $2.29 · Grant/award (A): 5,000 @ $2.30 | EDGAR |
| 2025-08-20 | 4 | Hoffman Michael B — Director | Grant/award (A): 6,717 @ $2.60 · Grant/award (A): 5,283 @ $2.59 · Grant/award (A): 5,545 @ $2.58 · Grant/award (A): 1,100 @ $2.57 | EDGAR |
| 2025-06-18 | 4 | Walsh Andrew — Vice President, Finance | Grant/award (A): 500 @ $2.90 | EDGAR |
| 2025-06-16 | 4 | Hoffman Michael B — Director | Grant/award (A): 25,000 @ $2.80 · Grant/award (A): 1 @ $2.83 | EDGAR |
| 2025-06-11 | 4 | McCarthy Reid — Director | Grant/award (A): 2,000 @ $2.95 | EDGAR |
| 2025-06-05 | 4 | Maccecchini Maria-Luisa — President & CEO, Director | Grant/award (A): 46,000 @ $3.37 | EDGAR |
| 2025-06-02 | 4 | Hoffman Michael B — Director | Grant/award (A): 5,000 @ $2.43 | EDGAR |
| 2024-07-03 | 4 | White Mark K. — Director | Grant/award (A): 26,200 (derivative) @ $0 · Grant/award (A): 2,146 (derivative) @ $0 · Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | McCarthy Reid — Director | Grant/award (A): 29,600 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | Bruck Claudine — Director | Grant/award (A): 26,200 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | Maccecchini Maria-Luisa — President and CEO, Director, 10% owner | Gift (G): 10,000 @ $0 · Gift (G): 10,000 @ $0 · Gift (G): 10,000 @ $0 · Grant/award (A): 252,000 (derivative) @ $0 · Grant/award (A): 108,800 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | Hoffman Michael B — Director, 10% owner | Grant/award (A): 29,600 (derivative) @ $0 | EDGAR |
| 2023-11-22 | 4/A | White Mark K. — Director | Grant/award (A): 1,990 @ $6.10 | EDGAR |
| 2023-11-22 | 4/A | McCarthy Reid — Director | Other (J): 0 @ $0 | EDGAR |
| 2023-11-22 | 4/A | Hagopian Henry III — Chief Financial Officer | Grant/award (A): 820 @ $6.10 | EDGAR |
| 2023-11-22 | 4/A | Bruck Claudine — Director | Other (J): 0 @ $0 | EDGAR |
| 2023-11-22 | 4/A | Maccecchini Maria-Luisa — President and CEO, Director, 10% owner | Grant/award (A): 40,970 @ $6.10 | EDGAR |
| 2023-11-22 | 4/A | Hoffman Michael B — Director, 10% owner | Grant/award (A): 163,880 @ $6.10 | EDGAR |
| 2023-11-21 | 4 | McCarthy Reid — Director | Grant/award (A): 824 @ $6.07 | EDGAR |
| 2023-11-21 | 4 | White Mark K. — Director | Grant/award (A): 2,000 @ $6.07 | EDGAR |
| 2023-11-21 | 4 | Hagopian Henry III — Chief Financial Officer | Grant/award (A): 824 @ $6.07 | EDGAR |
| 2023-11-21 | 4 | Bruck Claudine — Director | Grant/award (A): 1,000 @ $6.07 | EDGAR |
| 2023-11-21 | 4 | Maccecchini Maria-Luisa — President and CEO, Director, 10% owner | Grant/award (A): 41,186 @ $6.07 | EDGAR |
| 2023-11-21 | 4 | Hoffman Michael B — Director, 10% owner | Grant/award (A): 164,745 @ $6.07 | EDGAR |
| 2023-04-26 | 4 | Maccecchini Maria-Luisa — President and CEO, Director, 10% owner | Gift (G): 3,000 @ $0 | EDGAR |
| 2023-04-11 | 4 | White Mark K. — Director | Grant/award (A): 3,000 @ $12.61 | EDGAR |
| 2023-04-11 | 4 | Bruck Claudine — Director | Grant/award (A): 500 @ $12.61 | EDGAR |
| 2023-04-11 | 4 | Hagopian Henry III — Chief Financial Officer | Grant/award (A): 1,000 @ $12.61 | EDGAR |
| 2023-04-11 | 4 | McCarthy Reid — Director | Grant/award (A): 476 @ $12.61 | EDGAR |
| 2023-04-11 | 4 | Maccecchini Maria-Luisa — President and CEO, Director, 10% owner | Grant/award (A): 20,000 @ $12.61 | EDGAR |
| 2023-04-11 | 4 | Hoffman Michael B — Director, 10% owner | Grant/award (A): 59,477 @ $12.61 | EDGAR |
| 2023-02-08 | 4 | Maccecchini Maria-Luisa — President and CEO, Director, 10% owner | Option exercise (M): 52,755 @ $0.14 · Option exercise (M): 52,755 (derivative) @ $0 | EDGAR |
| 2023-01-20 | 4 | Hagopian Henry III — Chief Financial Officer | Grant/award (A): 7,672 (derivative) @ $0 | EDGAR |
| 2023-01-20 | 4 | White Mark K. — Director | Grant/award (A): 5,967 (derivative) @ $0 | EDGAR |
| 2023-01-20 | 4 | McCarthy Reid — Director | Grant/award (A): 5,967 (derivative) @ $0 | EDGAR |
| 2023-01-20 | 4 | Bruck Claudine — Director | Grant/award (A): 5,967 (derivative) @ $0 | EDGAR |
| 2023-01-20 | 4 | Maccecchini Maria-Luisa — President and CEO, Director, 10% owner | Grant/award (A): 21,312 (derivative) @ $0 | EDGAR |
| 2023-01-20 | 4 | Hoffman Michael B — Director, 10% owner | Grant/award (A): 6,820 (derivative) @ $0 | EDGAR |
| 2022-08-31 | 4 | Hagopian Henry III — Chief Financial Officer | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Annovis Bio, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-05 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-04 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-04 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 8.01 — Other Events | EDGAR |
| 2026-10-30 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-20 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-10 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-17 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-20 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ANVS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs